|
|
|
Welcome
to LymphomaLinks,
your monthly source of lymphoma news, research
updates, clinical trials and events sponsored by
The Leukemia & Lymphoma Society (LLS). For
even more information, regularly visit
LLS's Patient
Services and Disease
Information Web
sections. | |
 |
|
|
|
LLS
Features
::READ MORE::
.....................................................................................................................................
Research
Roundup
::READ MORE::
.....................................................................................................................................
IRC Question of
the Month
:: READ
MORE::
| |
|
|
Inspirational
Stories
 Learn how individuals touched
by blood cancer cope. LLS's LifeMosaic Web feature offers
hundreds of inspiring stories by patients and families. Read
them or submit your own. This
month, meet David. |
Here to
Help
For
even more information, regularly visit the LLS
Web site,
www.LLS.org
,
where many of our education programs are
archived free of charge for convenient access
24/7.
If you haven't found what you're
looking for in LymphomaLinks , please
call our Information Resource Center (IRC) to
speak with trained information specialists. IRC
staff are available Monday through Friday, 9
a.m. to 6 p.m. ET, toll free at (800) 955-4572;
email
infocenter@lls.org
;
or click the "Live Patient Help" button on
the www.LLS.org
homepage.
| |
|
|
Commentary
Deborah Banker, Ph.D., shares more
news on immunotherapies.
Clinical
Trials
We
invite you to use
our LLS-supported TrialCheck®
Web site, a clinical trial search service
that offers patients and caregivers immediate
access to listings of
all lymphoma clinical trials. Answer
just a few simple questions and a list of
available clinical trials related to your cancer
will appear in an easy to read list of search
results.
You may also want to visit the
National Cancer Institute's Cancer
Trials Support Unit, providing resources and
information on phase III cancer treatment trials
supported by the National Cancer
Institute
. ::SELECTED TRIALS::
Newsfeeds &
Podcasts
Now you can get
RSS Feeds and Podcasts from LLS.
::CLICK HERE TO SIGN
UP::
Free
eNewsletters
Free LLS
eNewsletters deliver the latest information on
research and treatment options, patient services
programs and fundraising events.
:: CLICK HERE TO SIGN
UP::
| | | |
| 
| | | |
|
|
|
My
Personal Lymphoma Journey
This unique
interactive Web program follows the stories and
experiences of lymphoma survivors, including a
new story of a follicular lymphoma survivor. The
guest physician is John P. Leonard, MD, of Weill
Medical College of Cornell University/New
York-Presbyterian Hospital, New York, NY. We
hope this program helps you to learn more about
the lymphoma journey, and resources that are
available to you and other lymphoma
survivors.
My
Clinical Trials Journey
This personalized
and interactive program follows the stories and
experiences of three cancer survivors who have
participated in clinical trials, including a
lymphoma survivor. Their stories of hope and
determination are compelling. Ann Pirro,
Physician's Assistant at Queens Medical Center,
Fresh Meadows, NY, provides expert insights
along the
way.
LLS
Advocacy
LLS's
advocacy team represents the needs of cancer
patients and their families in Washington,
DC and state capitals throughout the United
States. We need your help. Join our
Advocates Network and make your voice heard.
TAKE
ACTION: Urge Your Representative to Support
Increased Cancer Research Funding - Tell
your elected officials that to win the war on
cancer, they need to fund the war on
cancer!
Patient
Services Survey
Please give us your
feedback by completing LLS Disease &
Treatment Publications - Survey for Patients,
Family and Friends.
LLS Blog
Learn the many ways you can help advance the
LLS mission, including making a donation.
Find
out more about our other
eNewsletters.
> Back to the
top
| |
|
Mutant Protein Implicated in Diffuse Large
B-cell Lymphoma ::READ
MORE::
A Phase II study of SGN-30 (anti-CD30 mAb) in
Hodgkin lymphoma or systemic anaplastic large
cell lymphoma. ::READ
MORE::
Humanized Anti-CD20 Antibody, Veltuzumab, in
Refractory/Recurrent Non-Hodgkin's Lymphoma:
Phase I/II Results. ::READ
MORE::
A phase II trial of single agent bevacizumab
in patients with relapsed, aggressive
non-Hodgkin lymphoma: Southwest oncology group
study S0108. ::READ
MORE::
Blood-Brain Barrier Disruption and
Intra-Arterial Methotrexate-Based Therapy for
Newly Diagnosed Primary CNS Lymphoma: A
Multi-Institutional Experience. ::READ
MORE::
>Back to the
top
| |
Selected
Trials
Phase II: Bendamustine Combined With
Rituximab for Patients with Relapsed or
Refractory Diffuse Large B-Cell Lymphoma ::READ
MORE::
A Phase 1-2, Multicenter, Open-Label Study of
AEG35156 in Patients with Relapsed or Refractory
Chronic Lymphocytic Leukemia and Indolent B-Cell
Lymphomas ::READ
MORE::
Safety and Efficacy of RAD001 in Patients
with Velcade® Refractory Mantle Cell Lymphoma
::READ
MORE::
Study of Repeat Intranodal Injection of
Memgen's Cancer Vaccine, Ad-ISF35, in Subjects
with Non-Hodgkin's Lymphoma (Follicular, Diffuse
Large Cell, Mantle Cell, and Small Lymphocytic
Lymphoma/Chronic Lymphocytic Leukemia ::READ
MORE::
Phase II: Temsirolimus for
Relapsed/Refractory Hodgkin's Lymphoma ::READ
MORE::
A Pivotal Open-Label Trial of SGN-35 for
Hodgkin Lymphoma ::READ
MORE::
>Back to the
top
| |
| IRC
Question of
the Month | 
Q: I am
scheduled to have radiation therapy as part of
my treatment for lymphoma. What side effects can
I expect from this form of treatment?
A: Radiation therapy, also
known as radiotherapy, works by damaging the
genetic material (DNA) within cells, which
prevents them from growing and reproducing.
Although the therapy targets cancer cells,
healthy cells near the cancer cells may also be
damaged. A goal of radiotherapy is to protect
the healthy cells as much as possible, so that
the benefit (destroying cancer cells) outweighs
the risk (harming healthy cells). Side effects
usually occur as a result of the radiation on
tissue that contains rapidly dividing cells.
This includes the hair follicles and the
gastrointestinal tract lining.
Some patients may have no noticeable side
effects or very mild ones. For others, there can
be side effects of a type and severity that
depend on the dose, location, and duration of
the radiation. If radiation is given as
conditioning treatment prior to stem cell
transplant (total body radiation) then more
intense side effects may occur. Side effects of
radiation therapy may include increased fatigue,
hair loss, diarrhea, nausea, loss of appetite,
skin irritation and mouth sores (mucositis).
Most side effects will gradually go away after
the treatment is finished. Discuss the
course and effects of your treatment with your
doctor and radiation therapist.
Radiotherapy may cause long-term and late
effects (side effects that become apparent
months or years after the completion of
treatment). These effects depend on such factors
as the age of the patient and the dose and
location of treatment. Some potential long-term
and late effects of radiation therapy are the
development of a second cancer or infertility.
It is important to discuss long-term and late
effects with members of your oncology team
before treatment begins.
During and after radiotherapy you need to get
plenty of rest and follow a nutritious diet.
Eating well during and after therapy will help
you to cope with side effects, fight infection,
rebuild healthy tissue and maintain body weight
and energy. You also need to follow your
physician's advice about caring for the areas of
skin that were exposed to radiation.
For more information on radiation therapy and
side effects, you may access the LLS
Radiation Therapy Web page. You can also
view, print or order the free LLS fact sheets Long-Term
and Late Effects of Treatment in Adults and
Long-Term
and Late Effects of Treatment for Childhood
Leukemia or Lymphoma.
Please call our
Information Resource Center (IRC) to speak with
a trained information specialist. IRC staff are
available Monday through Friday, 9 a.m. to 6
p.m. ET, toll free at (800) 955-4572. Contact us
online or click the "Live
Patient Help" button on the www.LLS.org
homepage.
> Back to the
top
| |
| | | |
|
|
 |
Supported by an
unrestricted
educational grant
from
 |
 |
|
Contact Us: The
Leukemia & Lymphoma Society, 1311 Mamaroneck
Ave., White Plains, NY 10605, (800)
955-4572
|
|
| Visit our e-Store
& Special Offers page where you can
support businesses that support
LLS. | | | | | |
|
| | | |
